MeiraGTx Holdings (MGTX) Revenue (QoQ) (2019 - 2025)
MeiraGTx Holdings (MGTX) Revenue (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | MeiraGTx Holdings | 984.87 Mn | 918.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18,281.46% |
| Sep 30, 2025 | -88.89% |
| Dec 31, 2024 | 96.06% |
| Sep 30, 2024 | 3,768.79% |
| Jun 30, 2024 | -59.54% |
| Mar 31, 2024 | -65.83% |
| Dec 31, 2023 | -60.02% |
| Sep 30, 2023 | 44.15% |
| Jun 30, 2023 | 6.18% |
| Mar 31, 2023 | 163.05% |
| Dec 31, 2022 | -209.80% |
| Sep 30, 2022 | -55.24% |
| Jun 30, 2022 | 91.00% |
| Mar 31, 2022 | -73.23% |
| Dec 31, 2021 | 202.86% |
| Sep 30, 2021 | 35.81% |
| Jun 30, 2021 | 11.34% |
| Mar 31, 2021 | 21.30% |
| Dec 31, 2020 | -25.61% |
| Sep 30, 2020 | 105.82% |